Holen Sie sich die Stockscreener-App
0.4378
1.89%
0.0081
Handel nachbörslich:
.44
0.0022
+0.50%
Schlusskurs vom Vortag:
$0.4297
Offen:
$0.4297
24-Stunden-Volumen:
341.86K
Relative Volume:
0.52
Marktkapitalisierung:
$3.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-18.35M
KGV:
-0.3774
EPS:
-1.16
Netto-Cashflow:
$-19.20M
1W Leistung:
+12.17%
1M Leistung:
-12.79%
6M Leistung:
-74.55%
1J Leistung:
-99.66%
1-Tages-Spanne:
$0.414
$0.4489
1-Wochen-Bereich:
$0.3654
$0.4489
52-Wochen-Spanne:
$0.3654
$144.38
Theriva Biologics Inc Stock (TOVX) Company Profile
Firmenname
Theriva Biologics Inc
Sektor
Branche
Telefon
301 417 4364
Adresse
9605 Medical Center Drive, Suite 270, Rockville
Vergleichen Sie TOVX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TOVX
Theriva Biologics Inc
|
0.4378 | 3.89M | 0 | -18.35M | -19.20M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Theriva Biologics Inc Aktie (TOVX) Neueste Nachrichten
Can trapped investors hope for a rebound in Theriva Biologics Inc.Chart Signals & Precise Entry and Exit Recommendations - Newser
Trendline Breach Raises Concern for Theriva Biologics Inc. InvestorsQuarterly Portfolio Review & Risk Controlled Swing Trade Alerts - 선데이타임즈
What recovery options are there for Theriva Biologics Inc.Quarterly Portfolio Review & High Conviction Buy Zone Alerts - Newser
Analyzing net buyer seller activity in Theriva Biologics Inc.Trade Risk Summary & Safe Entry Zone Identification - Newser
Is Theriva Biologics Inc. a candidate for recovery playJuly 2025 Catalysts & Smart Swing Trading Alerts - Newser
Is Theriva Biologics Inc. stock reversal real or fake [2025 Technical Patterns]Real-Time Stock Movement Alerts - Newser
Is Theriva Biologics Inc. forming a reversal patternJuly 2025 Pullbacks & Verified Chart Pattern Signals - Newser
Why Theriva Biologics Inc. stock attracts strong analyst attentionFree Step-by-Step Trade Signal Implementation - Newser
What makes Theriva Biologics Inc. stock price move sharplySafe Momentum Strategy With Trend Analysis - Newser
Theriva Biologics Inc. Crosses 200 Day MA — Signal or NoiseEntry Zone Strategy for Consistent Profit Shared - beatles.ru
Theriva Biologics: Q2 Earnings Snapshot - New Haven Register
Theriva Biologics Faces Financial Risks Amid Shifting Trade Policies and Tariffs - TipRanks
Will Theriva Biologics Inc. stock go up soonProfit Target Planning with Exit Confidence - Newser
Theriva Biologics Reports Promising Trial Results and Financials - TipRanks
Theriva™ Biologics Reports Second Quarter 2025 Operational Highlights and Financial Results - GlobeNewswire
Theriva Biologics reports Q2 2025 financials, $12.1mln cash, VCN-01 data positive. - AInvest
Breakthrough: Theriva's VCN-01 Drug Shows Survival Benefits in Phase 2b Pancreatic Cancer Trial - Stock Titan
Theriva Biologics Inc. stock daily chart insightsSmart Risk Entry Zone Technical Analysis - Newser
How high can Theriva Biologics Inc. stock price go in 2025Alpha Trade Flow With Risk Calibration - Newser
Will earnings trigger a reversal in Theriva Biologics Inc.Free Early Entry Picks Before News Breakout - Newser
Is Theriva Biologics Inc. stock reversal real or fakeConsistent Gain Plan with AI Support - Newser
How Theriva Biologics Inc. stock performs during market volatilityEquity Signal Recap With Long-Term Summary - Newser
Detecting support and resistance levels for Theriva Biologics Inc.Chart Confirmation Setup with ROI Signals - Newser
How hedge fund analytics apply to Theriva Biologics Inc. stockSwing Entry Risk Mitigation with Chart Analysis - Newser
Can Theriva Biologics Inc. weather a recessionFree High Accuracy Stock Picks - sisaissue.com
Is Theriva Biologics Inc. stock ready for a breakout5-Year Price Trend Summary and Analysis - Newser
Signal strength of Theriva Biologics Inc. stock in tech scannersReliable Setup Screener with Low Risk - Newser
Theriva Biologics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayWatchlist Generator With Real-Time Entry - Newser
How does Theriva Biologics Inc. compare to its industry peersDiscover top stock picks for aggressive growth - Jammu Links News
Is Theriva Biologics Inc. stock overvalued or undervaluedSpectacular growth rates - Jammu Links News
Theriva Biologics Inc. Stock Analysis and ForecastMassive profits - Jammu Links News
What are analysts’ price targets for Theriva Biologics Inc. in the next 12 monthsUnlock powerful trading strategies for gains - Jammu Links News
How volatile is Theriva Biologics Inc. stock compared to the marketFree Technical Analysis Support - Jammu Links News
What is Theriva Biologics Inc. company’s growth strategyAmplify your gains with low-risk picks - Jammu Links News
How strong is Theriva Biologics Inc. company’s balance sheetAccess daily stock market expert updates - Jammu Links News
Is it the right time to buy Theriva Biologics Inc. stockMaximize returns with effective portfolio management - Jammu Links News
Finanzdaten der Theriva Biologics Inc-Aktie (TOVX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
Kapitalisierung:
|
Volumen (24h):